Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SAMRAT PHARMA Fact Sheet  (SMPH)



Access Now: Equitymaster's Premium Small Cap Research at 50% Off


Here is the latest financial fact sheet of SAMRAT PHARMA. For more details, see the SAMRAT PHARMA quarterly results and SAMRAT PHARMA share price. For a sector overview, read our pharmaceuticals sector report.

SAMRAT PHARMA Price History

Price Rs 430.0
Mkt Cap Rs m 1,328
Vol '000 5.0
P/E X 5.5
P/CF X 7.5
EPS (TTM) Rs 78.9
1 Day % -1.2
No. of shares m 3.09
1 Week % -16.1
1 Month % -21.2
1 Year % -7.8
52 week H/L Rs 1,250.0/332.0
As on Jun 2, 2023 11:29:00 AM
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SAMRAT PHARMA Financials

No. of Mths
Year Ending
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
12
Mar-22
*
5-Yr Chart
Click to enlarge
SAMRAT PHARMA EQUITY SHARE DATA
High Rs170164132159578 
Low Rs49494758135 
Sales per share (Unadj.) Rs260.6313.6381.2497.3613.6 
Earnings per share (Unadj.) Rs10.45.013.717.355.6 
Diluted earnings per shareRs10.45.013.717.355.6 
Cash flow per share (Unadj.) Rs11.76.315.118.957.5 
Dividends per share (Unadj.) Rs00001.00 
Adj. dividends per shareRs0.000.000.000.001.00 
Avg Dividend yield %00000.3 
Book value per share (Unadj.) Rs60.064.978.795.9151.5 
Adj. book value per shareRs60.064.978.795.9151.5 
Shares outstanding (eoy) m3.093.093.093.093.09 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x0.40.30.20.20.6 
Avg P/E ratio x10.521.46.56.36.4 
P/CF ratio (eoy) x9.316.85.95.86.2 
Price / Book Value ratio x1.81.61.11.12.4 
Dividend payout %00001.8 
Avg Mkt Cap Rs m3393282773351,101 
No. of employees `000NANANANANA 
Total wages/salary Rs m99101110 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
SAMRAT PHARMA INCOME DATA
Net Sales Rs m8059691,1781,5371,896 
Other income Rs m25656 
Total revenues Rs m8089741,1841,5411,902 
Gross profit Rs m60326687243 
Depreciation Rs m44456 
Interest Rs m91110137 
Profit before tax Rs m49225873236 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m176152064 
Profit after tax Rs m32154253172 
Gross profit margin %7.43.35.65.612.8 
Effective tax rate %34.628.826.827.427.2 
Net profit margin %4.01.63.63.59.1 
SAMRAT PHARMA BALANCE SHEET DATA
Current assets Rs m333328497473738 
Current liabilities Rs m210193339273373 
Net working cap to sales %15.213.913.413.019.2 
Current ratio x1.61.71.51.72.0 
Inventory Days Days32122 
Debtors Days Days99,196,73779,271,91086,186,005784839 
Net fixed assets Rs m767587101108 
Share capital Rs m3131313131 
"Free" reserves Rs m154170212265437 
Net worth Rs m185201243296468 
Long term debt Rs m83000 
Total assets Rs m408402583574846 
Interest coverage x6.73.06.96.836.0 
Debt to equity ratio x00000 
Sales to assets ratio x2.02.42.02.72.2 
Return on assets %10.06.48.911.521.1 
Return on equity %17.47.717.418.036.7 
Return on capital %30.015.827.829.151.8 
Exports to sales %12.219.05.98.95.7 
Imports to sales %80.987.194.786.880.6 
Exports (fob) Rs m9818469137107 
Imports (cif) Rs m6518441,1151,3341,528 
Fx inflow Rs m9818469137107 
Fx outflow Rs m6518441,1161,3341,528 
Net fx Rs m-553-660-1,046-1,198-1,421 
SAMRAT PHARMA CASH FLOW
From Operations Rs m 1 24 -13 48 178 
From Investments Rs m -24 22 -19 -29 -14 
From Financial Activity Rs m 15 -39 20 -19 -19 
Net Cashflow Rs m -8 6 -12 -0 145 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 48.6%
Institution 3.2%
Non-Institution 48.1%
Total 100.0%
Free Float 51.4%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2023
 

Company Information

Regd Off Plot No A2 / 3445, G I D C Phase 4, Opp. P C I, Ankleshwar - 393002
E-mail contact@samratpharmachem.in Web www.samratpharmachem.com
Tel 07045456789 / 07046456789 Fax 02646- 251291
Sector PHARMACEUTICALS Group Private sector
Tr Agent Link Intime India Pvt Ltd., C 101 247 Park, LBS Marg, Vikhroli (West)
CHM: Lalit Mehta COMP SEC: Nishant Kankaria YEAR OF INC: 1992 BSE CODE: 530125 FV (Rs): 10 DIV YIELD (%): 0.2

More Pharmaceuticals Company Fact Sheets:   AUROBINDO PHARMA    CIPLA    PIRAMAL ENTERPRISES    LUPIN    SUN PHARMA    

Compare SAMRAT PHARMA With:   AUROBINDO PHARMA    CIPLA    PIRAMAL ENTERPRISES    LUPIN    SUN PHARMA    




Today's Market

Sensex Today Trades Flat | Hero MotoCorp, TVS Motors Up 2% | IndusInd Bank & Infosys Top Losers Sensex Today Trades Flat | Hero MotoCorp, TVS Motors Up 2% | IndusInd Bank & Infosys Top Losers(10:30 am)

Asian shares markets are trading higher today after a renewed rally in tech giants pushed Wall Street indices higher ahead of jobs data due Friday as investors assess.